The goal of this work is to answer a question if the regulations of art. 160 § 1–3 k.k. could be used in combating designer drugs. The findings of this work are based on: 1) analysis of the normative materials referring to the examined issue; and – 2) analysis of the views presented in literature and judicature. As a result of said analyses it has been established that utilizing regulations of art. 160 § 1–3 k.k. could provide – at least in theory – an effective way of combating some of the socially undesirable behaviors related to designer drugs. However, it has to be stressed that proper interpretation of said regulation is extremely problematic (because of the legislator’s use of ambiguous phrases like: “exposure”, “danger”, “direct”).This can pose a serious obstacle in any attempts of using them in practice.